keyword
https://read.qxmd.com/read/38644153/donor-lung-preservation-at-10%C3%A2-c-clinical-and-logistical-impact
#1
JOURNAL ARTICLE
Mariana Gil Barturen, Rosalía Laporta Hernández, Antonio Romero Berrocal, Marina Pérez Redondo, Natalia Gómez Lozano, Javier Martín López, Ana Royuela Vicente, Alejandra Romero Román, Lucas Hoyos Mejía, Silvana Crowley Carrasco, David Gómez de Antonio, Jose Manuel Naranjo Gómez, Mar Córdoba Peláez, Nuria María Novoa, Jose Luis Campo-Cañaveral de la Cruz
INTRODUCTION: Cold static donor lung preservation at 10°C appears to be a promising method to safely extend the cold ischemic time (CIT) and improve lung transplant (LTx) logistics. METHODS: LTx from November 2021 to February 2023 were included in this single institution, prospective, non-randomized study comparing prolonged preservation at 10°C versus standard preservation on ice. The inclusion criteria for 10°C preservation were suitable grafts for LTx without any donor retrieval concerns...
April 6, 2024: Archivos de Bronconeumología
https://read.qxmd.com/read/38643128/heparin-free-veno-arterial-extracorporeal-membrane-oxygenation-in-lung-transplantation-a-retrospective-cohort-study
#2
JOURNAL ARTICLE
ZhaoMin Huang, Jiayi Zheng, Mingyang Wang, Shaoting Zeng, Miaoting Huang, Shuyi Peng, Jiajun Li, Jiaming Ji, Quan Chen, Xin Xu, Chao Yang, GuiLin Peng, Hanyu Yang
BACKGROUND: In lung transplantation (LTx) surgery, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can provide mechanical circulatory support to patients with cardiopulmonary failure. However, the use of heparin in the administration of ECMO can increase blood loss during LTx. This study aimed to evaluate the safety of heparin-free V-A ECMO strategies. METHODS: From September 2019 to April 2022, patients who underwent lung transplantation at the First Affiliated Hospital of Guangzhou Medical University were retrospectively reviewed...
April 20, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38626904/computed-tomography-based-body-composition-is-related-to-perioperative-morbidity-in-older-lung-transplant-recipients
#3
JOURNAL ARTICLE
Daria Kifjak, Helmut Prosch, Stefan Schwarz, Peter Jaksch, Michael Weber, Konrad Hoetzenecker, Thomas Schweiger
BACKGROUND:  In older patients, a limited physical reserve is considered a contraindication for lung transplantation (LTx). Herein, we aimed to establish a computed tomography (CT)-based quantification of physical reserve in older patients scheduled for transplantation. METHODS:  This retrospective study included patients older than 60 years who received LTx. Semiautomatic measurements of the mediastinal fat area and the dorsal muscle group area in pretransplantation CT scans were performed, and normalized data were correlated with clinical parameters...
April 16, 2024: Thoracic and Cardiovascular Surgeon
https://read.qxmd.com/read/38607291/lightgbm-outperforms-other-machine-learning-techniques-in-predicting-graft-failure-after-liver-transplantation-creation-of-a-predictive-model-through-large-scale-analysis
#4
JOURNAL ARTICLE
Rintaro Yanagawa, Kazuhiro Iwadoh, Miho Akabane, Yuki Imaoka, Kliment Krassimirov Bozhilov, Marc L Melcher, Kazunari Sasaki
BACKGROUND: The incidence of graft failure following liver transplantation (LTx) is consistent. While traditional risk scores for LTx have limited accuracy, the potential of machine learning (ML) in this area remains uncertain, despite its promise in other transplant domains. This study aims to determine ML's predictive limitations in LTx by replicating methods used in previous heart transplant research. METHODS: This study utilized the UNOS STAR database, selecting 64,384 adult patients who underwent LTx between 2010 and 2020...
April 2024: Clinical Transplantation
https://read.qxmd.com/read/38582719/kidney-transplantation-as-a-treatment-option-of-chronic-renal-failure-among-lung-transplant-recipients-a-single-center-experience
#5
JOURNAL ARTICLE
Marek Ochman, Fryderyk Zawadzki, Dagmara Galle, Anna Kowal, Magdalena Królikowska, Jawad Salman, Tomasz Hrapkowicz
INTRODUCTION: Chronic renal failure is one of the most common complications after solid organ transplantation. It is associated with multiple pre-, peri-, and post-transplant factors. In some patients, the available methods of conservative treatment are insufficient and kidney transplantation (KTx) is necessary. The aim of this study was to present our experience in the treatment of renal failure by KTx after lung transplantation (LTx). METHODS: Our study is a single-center retrospective review of clinical data of all 7 LTx recipients who underwent a KTx between the years 2013 and 2021...
April 5, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38580513/lung-transplantation-in-patients-with-pulmonary-hypertension-with-extracorporeal-membrane-oxygenation-ecmo-support-5-year-experience
#6
JOURNAL ARTICLE
Tomasz Stącel, Kamil Kegler, Agata Mędrala, Pawel Sybila, Marek Ochman, Mirosłąw Nęcki, Piotr Pasek, Igor Gummenyi, Anna Pióro, Piotr Przybyłowski, Tomasz Hrapkowicz, Maciej Urlik
Lung transplantation (LTx) is the only treatment option of patients (pts) with pulmo-nary hypertension (PH) when pharmacologic treatment is unsatisfactory. ECMO is essential during LTx in every patient with pulmonary arterial hypertension and in most patients with sec-ondary PH. This is a retrospective, single-center study comparing LTx outcomes in patients with and without PH covering a 5-year experience. In the years 2018-2023, 219 LTx were performed, of which 56 (25.6%) with ECMO support, among which PH was diagnosed in 34pts (60...
April 4, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38578337/letermovir-prophylaxis-for-cytomegalovirus-in-lung-transplant-recipients-a-comprehensive-study-with-literature-review-of-off-label-use-and-real-world-experiences
#7
REVIEW
Takashi Hirama, Yuki Shundo, Toshikazu Watanabe, Akihiro Ohsumi, Tatsuaki Watanabe, Yoshinori Okada
Letermovir, initially approved for cytomegalovirus (CMV) prophylaxis in hematopoietic stem-cell transplantation, has gained attention for off-label use in lung-transplant (LTx) recipients. Given the high susceptibility of LTx recipients to CMV infection, this study explores the effectiveness and safety of letermovir prophylaxis. A retrospective analysis of using letermovir for LTx recipients at Tohoku University Hospital (January 2000 to November 2023) was conducted. Case summaries from other Japanese transplant centers and a literature review were included...
April 5, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38546861/long-term-survival-and-clinical-outcomes-of-delayed-chest-closure-following-lung-transplantation
#8
JOURNAL ARTICLE
Takashi Hirama, Miki Akiba, Masahiro Ui, Saori Shibata, Fumiko Tomiyama, Tatsuaki Watanabe, Yui Watanabe, Hirotsugu Notsuda, Takaya Suzuki, Hisashi Oishi, Hiromichi Niikawa, Masafumi Noda, Yoshinori Okada
PURPOSES: Delayed chest closure (DCC) is a widely accepted procedure in the context of lung transplantation (LTx); yet there are few reports detailing its long-term survival and clinical outcomes. METHODS: We reviewed the medical records of recipients who underwent deceased-donor lung transplantation (LTx) at Tohoku University Hospital. Long-term survival, including overall survival, freedom from chronic lung allograft dysfunction (CLAD), and CLAD-free survival and the clinical outcomes of graft function and physical performance and constitution were reviewed in recipients with DCC...
March 28, 2024: Surgery Today
https://read.qxmd.com/read/38545099/ltx-315-triggers-anticancer-immunity-by-inducing-myd88-dependent-maturation-of-dendritic-cells
#9
JOURNAL ARTICLE
Xiao-Qing Li, Takahiro Yamazaki, Tianzhen He, Md Masud Alam, Jia Liu, Anna L Trivett, Baldur Sveinbjørnsson, Øystein Rekdal, Lorenzo Galluzzi, Joost J Oppenheim, De Yang
LTX-315 is a synthetic cationic oncolytic peptide with potent anticancer activity but limited toxicity for non-malignant cells. LTX-315 induces both immunogenic tumor cell death and generation of tumor-specific immune responses in multiple experimental tumor models. Given the central role of dendritic cell (DC) maturation in the induction of antigen-specific immunity, we investigated the effect of LTX-315 treatment on the maturation of tumor-infiltrating DCs (TiDCs) and the generation of anti-melanoma immunity...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38526116/heterotopic-auxiliary-whole-liver-rat-transplant-model-utilizing-a-hepaticoureterostomy-for-allograft-rejection-studies
#10
JOURNAL ARTICLE
Bret Verhoven, Weifeng Zeng, Peter Chlebeck, Kristina Matkowskyj, Heather Jennings, Samuel Poore, David Al-Adra
Small animal transplant models are indispensable for organ tolerance studies investigating feasible therapeutic interventions in preclinical studies. Rat liver transplantation (LTx) protocols typically use an orthotopic model where the recipients' native liver is removed and replaced with a donor liver. This technically demanding surgical procedure requires advanced micro-surgical skills and is further complicated by lengthy anhepatic and lower body ischemia times. This prompted the development of a less complicated heterotopic method that can be performed faster with no anhepatic or lower body ischemia time, reducing post-surgery stress for the recipient animal...
March 8, 2024: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/38523356/the-impact-of-lung-transplantation-on-esophageal-motility-and-inter-relationships-with-reflux-and-lung-mechanics-in-patients-with-restrictive-and-obstructive-respiratory-disease
#11
JOURNAL ARTICLE
Ali Alghubari, Ramsah Cheah, Sadia Z Shah, Abdel-Rahman N Naser, Augustine S Lee, Kenneth R DeVault, Lesley A Houghton
BACKGROUND: For many patients with lung disease the only proven intervention to improve survival and quality of life is lung transplantation (LTx). Esophageal dysmotility and gastroesophageal reflux (GER) are common in patients with respiratory disease, and often associate with worse prognosis following LTx. Which, if any patients, should be excluded from LTx based on esophageal concerns remains unclear. Our aim was to understand the effect of LTx on esophageal motility diagnosis and examine how this and the other physiological and mechanical factors relate to GER and clearance of boluses swallowed...
March 24, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38502914/lower-uromodulin-serum-levels-are-associated-with-poorer-prognosis-in-patients-with-cirrhosis-and-hepatorenal-syndrome-type-2
#12
JOURNAL ARTICLE
Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven, Charlotte Sophie Hock, Henrike Dobbermann, Sophia Heinrich, Myriam Meineck, Leonard Kaps, Peter Robert Galle, Julia Weinmann-Menke, Marc Nguyen-Tat, Jens Uwe Marquardt, Christian Labenz
Hepatorenal syndrome (HRS) is associated with a dismal prognosis in patients with cirrhosis, and therapeutic options are limited. Biomarkers to identify patients with poor response to therapy are urgently needed. This study aimed to evaluate the predictive value of serum levels of Uromodulin (sUMOD) in patients with cirrhosis and HRS treated with terlipressin and albumin (T/A). In total, 156 patients (81 patients with HRS treated with T/A, 42 patients with cirrhosis without kidney injury and 33 patients with cirrhosis with prerenal acute kidney injury (AKI)) were included...
March 19, 2024: American Journal of Physiology. Gastrointestinal and Liver Physiology
https://read.qxmd.com/read/38495394/teriparatide-as-treatment-for-severe-osteoporosis-in-lung-transplant-recipients
#13
Lisa M Raven, Louise Goodall, Jacqueline R Center, Christopher A Muir
Osteoporosis and osteopenia are common in lung transplant (LTx) recipients, with a significantly increased incidence compared to other non-lung solid organ transplant patients. Despite high fracture rates, including in patients treated with antiresorptive medications, there are limited data on the use of anabolic treatments in LTx recipients. We present clinical, biochemical and bone mineral density data for 3 patients with severe osteoporosis treated with teriparatide 20 micrograms daily for 18 months post-LTx...
March 2024: JCEM Case Rep
https://read.qxmd.com/read/38490642/the-use-of-extracorporeal-photopheresis-in-solid-organ-transplantation-current-status-and-future-directions
#14
REVIEW
Markus J Barten, Andrew Fisher, Alexandre Hertig
Prevention and management of allograft rejection urgently require more effective therapeutic solutions. Current immunosuppressive therapies used in solid organ transplantation, while effective in reducing the risk of acute rejection, are associated with substantial adverse effects. There is therefore a need for agents that can provide immunomodulation supporting graft tolerance, while minimizing the need for immunosuppression. Extracorporeal photopheresis (ECP) is an immunomodulatory therapy currently recommended in international guidelines as an adjunctive treatment for the prevention and management of organ rejection in heart (HTx) and lung (LTx) transplantation...
March 13, 2024: American Journal of Transplantation
https://read.qxmd.com/read/38461880/successful-lung-transplantation-in-genetic-mars-related-alveolar-proteinosis-lung-fibrosis-without-recurrence-under-methionine-supplementation-medium-term-outcome-in-4-cases
#15
Charlotte Roy, Nathalie Allou, Aurore Coulomb, Dominique Grenet, Raphaël Borie, Benjamin Zuber, Abdulmonem Hamid, Matthieu Glorion, Anne-Laure Brun, Elizabeth Longchamps, Alice Hadchouel, Olivier Brugiere
Pulmonary alveolar proteinosis (PAP) results from the accumulation of lipoproteinaceous material in the alveoli and alveolar macrophages, and can be associated with pulmonary fibrosis (PAP-PF), with a need for lung transplantation (LTx). Causes of PAP are autoimmune (90-95%), secondary (5%), or hereditary (<1%). Patients with hereditary PAP are generally not considered for isolated LTx, due to the high probability of recurrence after LTx, and only a challenging scenario with sequential LTx followed by HSCT was reported as successful...
March 8, 2024: American Journal of Transplantation
https://read.qxmd.com/read/38449519/pulmonary-vascular-pressure-respiratory-swings-in-copd-and-ild-candidates-for-lung-transplantation-large-but-different
#16
JOURNAL ARTICLE
Juan C Grignola, Alvaro Calabuig, Pedro Trujillo, Carles Bravo, Fernando Azpiroz, Manuel López Messeguer, Enric Domingo
We analyzed the effect of respiratory swings on interpreting intravascular pulmonary vascular pressures (PVPs) in chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) candidates for lung transplantation (LTx) and the role of the alterations in pulmonary function tests on the dynamic respiratory variations. Twenty-eight consecutive patients were included. All patients underwent a complete hemodynamic study (right atrial, mean pulmonary arterial, and pulmonary arterial occlusion pressures [RAP, mPAP, and PAOP]-) and pulmonary function testing (force vital capacity [FVC], forced expiratory volume in the first second [FEV1], and residual volume [RV])...
January 2024: Pulmonary Circulation
https://read.qxmd.com/read/38448059/protocol-for-venoarterial-extracorporeal-membrane-oxygenation-to-reduce-morbidity-and-mortality-following-bilateral-lung-transplantation-the-ecmotop-randomised-controlled-trial
#17
JOURNAL ARTICLE
Jonathan Messika, Philippine Eloy, David Boulate, Aude Charvet, Julien Fessler, Jacques Jougon, Philippe Lacoste, Olaf Mercier, Philippe Portran, Hadrien Roze, Edouard Sage, Jacques Thes, Francois Tronc, Mickael Vourc'h, Philippe Montravers, Yves Castier, Herve Mal, Pierre Mordant
INTRODUCTION: Lung transplantation (LTx) aims at improving survival and quality of life for patients with end-stage lung diseases. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used as intraoperative support for LTx, despite no precise guidelines for its initiation. We aim to evaluate two strategies of VA-ECMO initiation in the perioperative period in patients with obstructive or restrictive lung disease requiring bilateral LTx. In the control 'on-demand' arm, high haemodynamic and respiratory needs will dictate VA-ECMO initiation; in the experimental 'systematic' arm, VA-ECMO will be pre-emptively initiated...
March 5, 2024: BMJ Open
https://read.qxmd.com/read/38410547/the-efficacy-of-pulmonary-rehabilitation-training-program-for-patients-after-lung-transplantation
#18
JOURNAL ARTICLE
Jie Mei, Jing Hu, Eric M Krause, Toyofumi F Chen-Yoshikawa, Antonio Alvarez, Xiaojun Wang
BACKGROUND: Pulmonary rehabilitation is recognized widely as one of the most effective measures to promote postoperative recovery of lung transplant recipients (LTRs), and it has positive effects on both short- and long-term quality of life (QoL) and survival outcomes. However, no standardized pulmonary rehabilitation training programs exist specifically for LTRs. The pulmonary rehabilitation programs widely used in clinical practice focus mainly on exercise or respiratory training, to some extent neglecting other therapeutic methods that could promote patient health, such as nutrition support, pain control, spiritual comfort, and so on...
January 30, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38404627/reoperative-cabg-in-a-patient-with-prior-concomitant-lung-transplantation-and-two-vessel-cabg
#19
Emily L Larson, Anson Y Lee, Jennifer S Lawton, Hamza Aziz
BACKGROUND: Lung transplants (LTx) are being offered to increasingly older patients, and as a result, more concomitant coronary artery disease is being encountered in LTx candidates. While concurrent coronary artery bypass grafting (CABG) and LTx have become more common, the long-term considerations of reoperative CABG in patients following CABG with concomitant LTx are not fully understood. CASE PRESENTATION: A 75-year-old man with a history of bilateral LTx and concomitant CABG X 2 15 years prior presented to the emergency room with tachycardia and chest discomfort radiating to the left upper extremity...
September 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/38392766/multi-locus-microsatellite-typing-of-colonising-and-invasive-aspergillus-fumigatus-isolates-from-patients-post-lung-transplantation-and-with-chronic-lung-disease
#20
JOURNAL ARTICLE
Joshua D Birnie, Tanveer Ahmed, Sarah E Kidd, Glen P Westall, Gregory I Snell, Anton Y Peleg, Catherine Orla Morrissey
Aspergillus fumigatus can cause different clinical manifestations/phenotypes in lung transplant (LTx) recipients and patients with chronic respiratory diseases. It can also precipitate chronic lung allograft dysfunction (CLAD) in LTx recipients. Many host factors have been linked with the severity of A. fumigatus infection, but little is known about the contribution of different A. fumigatus strains to the development of different phenotypes and CLAD. We used multi-locus microsatellite typing (MLMT) to determine if there is a relationship between strain (i...
January 24, 2024: Journal of Fungi (Basel, Switzerland)
keyword
keyword
69264
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.